Develops, manufactures and markets products and services globally for the treatment of severe bone defects, initially in the skull area. Vision is to be perceived by patients and caregivers as the leading supplier in selected focus areas.
CRO (Contract Research Organization) främst inom preklinisk forskning, tyngdpunkten ligger på kemi (syntes och analytisk). Företaget bedriver även konsultverksamhet till forskningsbolag.
TailorDose™ is a new patented technology that allows individual dose adjustment of chemotherapy based on measurement of specific biomarkers in a single blood sample.
Cavidi’s new technology improves HIV diagnosis and, therefore, the effectiveness of treatment in high-prevalence countries. This allows greater and better care to be delivered at a lower cost.
